Pharmacists Take Charge During an In-Flight Medical Emergency
Drug Topics
DECEMBER 9, 2022
A group of pharmacists rose to the occasion to help a man having a medical emergency aboard a recent United flight bound for Newark, New Jersey.
Fri.Dec 09, 2022
275 
ICYMI: PhRMA COO Lori Reilly speaks about the health care agenda for the next Congress
PhRMA
DECEMBER 9, 2022
With a divided Congress, bipartisan action will be necessary to move the needle on health care policy. On December 7, 2022, PhRMA sponsored the Axios event, “ The Post-Midterm Health Care Agenda ,” where I participated in a View from the Top segment with Nicholas Johnston, publisher of Axios. We discussed PhRMA’s focus on passing the PASTEUR Act in the last few weeks of 2022, and laid out PhRMA’s priorities heading into 2023 that will support and protect patients.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Best of the Best: Delaney Santon, CPHT, on How Pharmacy Techs Help Patients
Drug Topics
DECEMBER 9, 2022
Winner of SingleCare's Best of the Best: Best Pharmacy Technician, Santon joined Drug Topics® to discuss what pharmacy technicians can do for patients and why it's so important to her for every patient to afford their medication.
Opinion: Artificial intelligence: crossing the border between health care and tech
STAT
DECEMBER 9, 2022
There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson. The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Legislation Must Control Drug Prices and Support Innovations like Biosimilars
Drug Topics
DECEMBER 9, 2022
The U.S. biosimilar landscape is changing, and legislation may be the key to controlling drug prices and advancing the market.
Updated USPSTF Guidelines Show Benefits of Screening for Obstructive Sleep Apnea Do Not Outweigh Harms
Pharmacy Times
DECEMBER 9, 2022
The decision is updated from a 2017 recommendation to screen people for obstructive sleep apnea, which can lead to daytime sleepiness and other adverse outcomes.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Research Supports Efficacy, Safety of Palivizumab Preventing Lower Respiratory Tract Infections by RSV
Pharmacy Times
DECEMBER 9, 2022
Palivizumab is a humanized monoclonal antibody approved by the FDA to prevent serious lower respiratory tract infection caused by respiratory syncytial virus in infants and young children.
IHI Forum: Don Berwick calls out greed, rallies industry to protest monetization of healthcare
Fierce Healthcare
DECEMBER 9, 2022
IHI Forum: Don Berwick calls out greed, rallies industry to protest monetization of healthcare. agliadkovskaya. Fri, 12/09/2022 - 18:09.
Study Confirms Benefit of Rivaroxaban for Secondary Prevention of Venous Thromboembolism in Patients With Cancer
Pharmacy Times
DECEMBER 9, 2022
At 3 and 6 months, rivaroxaban was found to be as effective and safe as apixaban in the composite outcome of recurrent venous thromboembolism or bleeding-related hospitalization.
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead
Fierce Pharma
DECEMBER 9, 2022
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead. aliu. Fri, 12/09/2022 - 09:15.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Case Study: Endobronchial Foreign Objects Can Present as Cough, Chest Pain
Pharmacy Times
DECEMBER 9, 2022
Clinicians should consider potential aspiration of illicit drug packets that were swallowed or inserted into the body.
Medscape physician survey reveals attitudes on anti-vaxxers, expensive treatment plans, other ethical dilemmas
Fierce Healthcare
DECEMBER 9, 2022
Medscape physician survey reveals attitudes on anti-vaxxers, expensive treatment plans, other ethical dilemmas. agliadkovskaya. Fri, 12/09/2022 - 12:40.
Treatment With Atrasentan Improves Albuminuria in Patients With Chronic Kidney Disease, Diabetes
Pharmacy Times
DECEMBER 9, 2022
Atrasentan has been found to lower albuminuria, which correlates with reductions in low-density lipoprotein cholesterol and triglycerides.
STAT+: Up and down the ladder: The latest comings and goings
STAT
DECEMBER 9, 2022
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Zavegepant Nasal Spray Shows Promise in Acute Treatment of Migraine
Pharmacy Times
DECEMBER 9, 2022
Zavegepant could become the first intranasal drug that targets CGRP in migraine sufferers to gain FDA approval.
Ballerina, firefighter, hygienist? Why dentistry needs to start its pipeline with young kids
STAT
DECEMBER 9, 2022
Dentistry has a diversity problem, and medical and dental experts say the best way to fix it is to start the pipeline early in Black and brown communities. “We can’t wait until someone graduates from undergrad to try to recruit an African American or Hispanic dentist,” Gillian Barclay, vice president of global public health at Colgate-Palmolive, said at the Milken Institute Future of Health Summit on Wednesday.
TDM1, Radiation Considered Safe for Patients with Early-Stage HER2-Positive Breast Cancer
Pharmacy Times
DECEMBER 9, 2022
Expert sits with Pharmacy Times to share the promising results of a study that evaluated the safety of a new antibody drug conjugate with radiation therapy.
STAT+: Why a tone-deaf Regeneron executive deserved to be booed over Alzheimer’s drug remarks
STAT
DECEMBER 9, 2022
File this under “What was he thinking?” The otherwise staid Milken Institute summit on health care grew unexpectedly heated on Thursday when George Yancopoulos, the Regeneron Pharmaceuticals president and chief scientific officer, drew boos from the crowd as he became cantankerous and talked over the panel moderator, who had expressed concern about access to high-priced Alzheimer’s medicines.
What is Stiff-Person Syndrome?
Board Vitals - Pharmacist
DECEMBER 9, 2022
World-renowned singer, Celine Dion, recently announced on her Instagram the cancellation of tour dates due to her diagnosis of Stiff-Person Syndrome. What is Stiff-Person Syndrome (SPS), and how is it diagnosed and treated? . What is SPS? Stiff-Person Syndrome (SPS) is an extremely rare disease , affecting only one out of every million people. In fact, many neurologists will go their entire careers and only see one or two instances of the condition.
The best SingleCare reviews of 2022
The Checkup by Singlecare
DECEMBER 9, 2022
It’s almost time to ring in a new year, and for many, that means setting resolutions to live healthier. Whether your goal is to lose weight, build muscle , or manage conditions like insulin resistance or Type 2 diabetes , SingleCare’s blog, The Checkup , has plenty of health and wellness articles to ensure you have a happy and healthy 2023. We’re also here to help you save big on your prescription costs year-round.
STAT+: Pharmalittle: Medicare willing to reevaluate coverage of Alzheimer’s drugs; judge tosses shingles-vaccine lawsuits against Merck
STAT
DECEMBER 9, 2022
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, appears to be rather modest. We plan to promenade extensively with the official mascot, tidy up around the castle, check in on the Pharmalot ancestors, and have a listening party with Mrs.
AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla
Fierce Pharma
DECEMBER 9, 2022
AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla. fkansteiner. Fri, 12/09/2022 - 09:22.
Get More Customers To Your Pharmacy
DiversifyRx
DECEMBER 9, 2022
Are you interested in getting more people into your pharmacy? While we often preach that volume does NOT equal profits, there is no denying that having more people enter your pharmacy sets you up for success. There are many strategies and tactics that you can use to increase your daily foot traffic into your pharmacy. Let’s dive deeper into our favorite low-cost methods.
Many Americans view the economy as a major healthcare concern: Oscar Health survey
Fierce Healthcare
DECEMBER 9, 2022
Many Americans view the economy as a major healthcare concern: Oscar Health survey. pminemyer. Fri, 12/09/2022 - 15:58.
ASH: Despite partial clinical hold, bluebird's sickle cell gene therapy remains on track
Fierce Pharma
DECEMBER 9, 2022
ASH: Despite partial clinical hold, bluebird's sickle cell gene therapy remains on track. kdunleavy. Fri, 12/09/2022 - 19:15.
Autolus announces primary endpoint met in FELIX trial, prices public offering
pharmaphorum
DECEMBER 9, 2022
Autolus Therapeutic Plc. (Nasdaq: AUTL), a clinical-stage biopharma and a portfolio company of Syncona Ltd., has announced that the pivotal phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic Leukaemia (ALL) patients has met its primary endpoint of overall remission rate (ORR) at interim analysis.
Senator presses Amgen with 'final request' for information in tax probe
Fierce Pharma
DECEMBER 9, 2022
Senator presses Amgen with 'final request' for information in tax probe. kdunleavy. Fri, 12/09/2022 - 09:50.
Oligonucleotide synthesis market to reach $16.7 billion by 2027
European Pharmaceutical Review
DECEMBER 9, 2022
According to a new market report by ResearchAndMarkets, the global oligonucleotide synthesis market is projected to reach $16.7 billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. The research projected a compound annual growth rate (CAGR) of 16.8 percent from $7.7 billion in 2022.
Mark Cuban's drug company targets self-insured employer market
Fierce Healthcare
DECEMBER 9, 2022
Mark Cuban's drug company targets self-insured employer market. hlandi. Fri, 12/09/2022 - 13:51.
AMR surveillance must improve, says WHO report
European Pharmaceutical Review
DECEMBER 9, 2022
The Global Antimicrobial Resistance and Use Surveillance System (GLASS) report 2022 by the World Health Organization (WHO), which contains AMR trends for the first time since 2017, showed that common bacterial infections are becoming increasingly resistant to treatments. Data from the 2022 GLASS report. The document includes data on antimicrobial consumption (AMC) in humans in 27 countries and analyses for antimicrobial resistance (AMR) rates in relation to national testing coverage.
Blue Shield of California partners with DispatchHealth for in-home care
Fierce Healthcare
DECEMBER 9, 2022
Blue Shield of California partners with DispatchHealth for in-home care. pminemyer. Fri, 12/09/2022 - 13:49.
Combo of Roche's Tecentriq and Exelixis' Cabometyx fails another trial, this time in lung cancer
Fierce Pharma
DECEMBER 9, 2022
Combo of Roche's Tecentriq and Exelixis' Cabometyx fails another trial, this time in lung cancer. fkansteiner. Fri, 12/09/2022 - 11:22.
As Twitter rolls back its ban on COVID misinformation, some health experts worry about threat to public health
Fierce Healthcare
DECEMBER 9, 2022
As Twitter rolls back its ban on COVID misinformation, some health experts worry about threat to public health. aburky. Fri, 12/09/2022 - 17:35.
Dr. Sy Pretorius, Eversana’s new COO, is flipping the script on his career
PharmaVoice
DECEMBER 9, 2022
With a long history in the clinical space, Pretorius is now applying those deep insights to the commercial side of the business.
Let's personalize your content